MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0037451
Tineta Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹119.85 Cr
▲ 17% YoY
Net profit · FY 2025
₹15.37 Cr
Net margin 12.8%
EBITDA · FY 2025
₹21.36 Cr
EBITDA margin 17.8%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.93 Cr
Issued & subscribed
Open charges
₹35 Cr
Satisfied ₹2.55 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
308
Provident fund records
About Tineta Pharma Private Limited
Data last updated:
Tineta Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 29 May 1995 and has been in existence for over 31 years.
Its director Sudhir Vijay Menon is #338 among India's richest people (2026). Its director Subodh Menon is #602 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1995PTC088871. Its GSTIN is 27AAACT3267F1ZE (Maharashtra).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.93 Cr. It is led by directors including Subodh Vijayaraghava Menon and Perumangode Neelkandhan Ramaswamy.
Its last annual general meeting (AGM) was held on 10 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 15/16 'Solaris – II' Premises Chs Ltd. Opp. L&T Gate 6 Saki Vihar Road Powai, Mumbai, Maharashtra, India – 400072.
As per the financials filed for FY 2025, the company reported a revenue of ₹119.85 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹15.37 Cr (net margin 12.8%) and EBITDA of ₹21.36 Cr (EBITDA margin 17.8%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 20% over five years.
The company has about 308 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Tineta Pharma. As per MCA filings, the company has open charges of ₹35 Cr and satisfied charges of ₹2.55 Cr on record. Court records list 49 cases involving the company, including 45 filed by the company and 4 filed against it; 7 cases are pending. The company has 7 deals on record (6 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.89 Cr; the latest was in March 2018. Its 10 peer companies in the Pharma industry (Animal Pharma) are compared by revenue, 5 larger and 5 smaller; the largest is Vital Therapeutics Private Limited with revenue of ₹145.15 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 9 overdue payments to 3 micro and small suppliers.
Tineta Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0037451). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tineta.com.
Company Details of Tineta Pharma Private Limited
CIN U24230MH1995PTC088871
Registration Number 088871
Incorporation Date 29 May 1995
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 10 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0037451
Key People
Subodh Vijayaraghava Menon Director Perumangode Neelkandhan Ramaswamy Director Sudhir Vijay Menon Director Recognitions & Rankings of Tineta Pharma
India's Richest People 2026 edition · 2 directors · Source: Hurun India
- #338 Sudhir Vijay Menon ₹11,100 Cr
- #602 Subodh Menon ₹5,600 Cr
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressG – 15/16 'Solaris – II' Premises Chs Ltd. Opp. L&T Gate 6 Saki Vihar Road Powai, Mumbai, Maharashtra, India – 400072
- IndustryPharma, Animal Pharmaceuticals & Healthcare
Comprehensive company report
Tineta Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Tineta Pharma Private Limited
Tineta Pharma operates one associated brand: Tineta Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies animal medicinal products and feed supplements for veterinary and agricultural use. | tineta.com |
Business Activity of Tineta Pharma Private Limited
The main business activity of Tineta Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Tineta Pharma Private Limited FY 2025 filings available
Tineta Pharma Private Limited reported revenue of ₹119.85 Cr (up 17% YoY) for FY 2025.
Revenue · FY 2025
₹119.85 Cr ▲ 17%
Net profit · FY 2025
₹15.37 Cr margin 12.8%
EBITDA · FY 2025
₹21.36 Cr margin 17.8%
Compounded Annual Growth Rate (CAGR) of Tineta Pharma Private Limited
Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 14%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▲ 108%
3 years · compounded
▲ 19%
5 years · compounded
▲ 74%
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 17% growth in the latest year. EBITDA rose 108% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Tineta Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹21.36 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹15.37 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Tineta Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 12.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Tineta Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Tineta Pharma Private Limited
Tineta Pharma has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subodh Vijayaraghava Menon | Director | 15 Feb 2024 | 2 Years 8 Months | Current |
| Perumangode Neelkandhan Ramaswamy Also directs: Fobeoz India Private Limited, Dorf-Ketal Chemicals India Limited, Nayam Energy Private Limited and 5 more | Director | 15 Feb 2024 | 2 Years 8 Months | Current |
| Sudhir Vijay Menon | Director | 15 Feb 2024 | 2 Years 8 Months | Current |
Peer Comparison of Tineta Pharma Private Limited
Tineta Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Animal Pharma). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vital Therapeutics Private Limited | ₹145.15 Cr (FY 2025) | •••• | •••• | -14.0% | •••• | Secunderbad, Telangana, India |
| Ceva Polchem Private Limited | ₹144.51 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Pune, Maharashtra, India |
| Quadragen Vethealth Private Limited | ₹133.64 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | Bangalore, Karnataka, India |
| Carus Laboratories Private Limited | ₹128.85 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Delhi, India |
| Harshvardhans Laboratories Private Limited | ₹123.35 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Dhar, Madhya Pradesh, India |
| Tineta Pharma Private Limited this company | ₹119.85 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| Rodec Pharma Limited | ₹108.15 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | New Delhi, Delhi, India |
| Panchsheel Organics Limited Listed | ₹107.68 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Indore, Madhya Pradesh, India |
| Ayurvet Limited | ₹107.61 Cr (FY 2023) | •••• | •••• | 3.0% | •••• | Ahmedabad, Gujarat, India |
| Indovax Private Limited | ₹105 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
| Timo Eva Wellness Private Limited | ₹102.77 Cr (FY 2024) | •••• | •••• | 31.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Tineta Pharma by revenue in the Pharma industry (Animal Pharma), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Tineta Pharma Private Limited
Tineta Pharma Private Limited is audited by PRAKASH BAKHDA & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PRAKASH BAKHDA & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Tineta Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Tineta Pharma Private Limited
Open charges
₹35 Cr
Satisfied charges
₹2.55 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2025 | Others | ₹35 Cr | Open |
| 05 Oct 2011 | State Bank of India | ₹1 Cr | Satisfied |
| 30 Jan 2006 | The Greater Bombay Co-Op Bank Ltd | ₹1.55 Cr | Satisfied |
Total charge records: 3 View all charges
Deals & Funding of Tineta Pharma Private Limited
Tineta Pharma Private Limited has 7 deals on record (6 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.89 Cr; the latest was in March 2018.
Total deals
7
Funding rounds
6
Secondary share transfer
1
Disclosed funding
₹1.89 Cr
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: Shreekant Pandurang Inamdar HUF Seller: 2 individuals |
| Mar 2016 | Funding round | ₹17.4 Lakh | Investors: Pradeep Verma HUF, Shreekant Pandurang Inamdar HUF, Vipin Chandan HUF, an individual |
| Mar 2015 | Funding round | ₹20.3 Lakh | Investors: Vipin Chandan HUF, Pradeep Verma HUF, 2 individuals |
| Feb 2013 | Funding round | ₹40.6 Lakh | Investors: Vipin Chandan HUF, Shreekant Pandurang Inamdar HUF, 2 individuals |
| Mar 2011 | Funding round | ₹36.9 Lakh | Investors: Shreekant Pandurang Inamdar HUF, Vipin Chandan HUF, Pradeep Verma HUF |
Premium access
Full deal history
All 7 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Tineta Pharma Private Limited
Tineta Pharma Private Limited has 49 court cases on record: 45 filed by Tineta Pharma, 4 filed against it. 7 cases are pending and 42 are disposed.
Total cases
49
Filed by the company
45
Filed against the company
4
Pending
7
Disposed
42
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 49 | 4 | 7 |
Cases on record (5 of 49)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Pending |
Premium access
Full case history
All 49 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Tineta Pharma Private Limited
Tineta Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 9 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| J Kantilal | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Tineta Pharma Private Limited
Tineta Pharma Private Limited has a workforce of 308 employees as of Apr 07, 2024.
Employee count
308
Active EPFO establishments
1
Employee growth
14.5%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Tineta Pharma Private Limited
Tineta Pharma Private Limited has 9 board changes on record since 2024: 3 appointments and 6 cessations. The latest: Perumangode Neelkandhan Ramaswamy ceased to be Additional Director on 27 Sep 2024.
AGM
Tineta Pharma Private Limited last Annual general meeting of members was held on 10 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 35.00 Cr with Charge ID 101155939 was registered on 28 Aug 2025.
Filing
Tineta Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Perumangode Neelkandhan Ramaswamy ceased to be Additional Director.
Ceased
Subodh Vijayaraghava Menon ceased to be Additional Director.
Ceased
Sudhir Vijay Menon ceased to be Additional Director.
Ceased
Pradeep Vidyasagar Verma ceased to be Director.
Ceased
Shreekant Pandurang Inamdar ceased to be Director.
Ceased
Vipin Volji Chandan ceased to be Whole-Time Director.
Appointed
Perumangode Neelkandhan Ramaswamy was appointed as Director.
Appointed
Subodh Vijayaraghava Menon was appointed as Director.
Appointed
Sudhir Vijay Menon was appointed as Director.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Tineta Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Tineta Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Tineta Pharma Private Limited
Tineta Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACT3267F1ZE | Maharashtra | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Tineta Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Tineta Pharma Private Limited
Frequently Asked Questions about Tineta Pharma Private Limited
Tineta Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 29 May 1995 (31+ years old) and is registered under CIN U24230MH1995PTC088871.
Tineta Pharma reported revenue of ₹119.85 Cr for FY 2025 (up 17% YoY).
Tineta Pharma has 3 current directors:
- Subodh Vijayaraghava Menon - Director
- Perumangode Neelkandhan Ramaswamy - Director
- Sudhir Vijay Menon - Director
Tineta Pharma reported a net profit of ₹15.37 Cr (net margin 12.8%) and EBITDA of ₹21.36 Cr (EBITDA margin 17.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Tineta Pharma is 14% over three years and 20% over five years. In the latest year (FY 2025) revenue rose 17%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Tineta Pharma is 27AAACT3267F1ZE, registered in Maharashtra.
The CIN (Corporate Identification Number) of Tineta Pharma is U24230MH1995PTC088871. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tineta Pharma has 49 court cases on record: 45 filed by the company and 4 filed against it. 7 are pending.
Tineta Pharma was incorporated on 29 May 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.
Tineta Pharma has 7 deals on record (6 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.89 Cr; the latest was in March 2018.
The peers of Tineta Pharma by revenue are Vital Therapeutics Private Limited, Ceva Polchem Private Limited, Quadragen Vethealth Private Limited, Carus Laboratories Private Limited, Harshvardhans Laboratories Private Limited and 5 more, all in the Pharma industry (Animal Pharma).
Perumangode Neelkandhan Ramaswamy ceased to be Additional Director on 27 Sep 2024. Subodh Vijayaraghava Menon ceased to be Additional Director on 27 Sep 2024. Sudhir Vijay Menon ceased to be Additional Director on 27 Sep 2024. Tineta Pharma has 9 board changes on record in total.